Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Ravaioli

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Melanoma Research|January 8, 2019
Time trends and age-period-cohort analysis of cutaneous malignant melanoma incidence rates in the Romagna Region (northern Italy), 1986-2014Silvia Mancini, Emanuele Crocetti, Lauro Bucchi, et al.
Journal of Medical Screening|August 27, 2020
Incidence of interval breast cancer among women aged 45-49 in an organised mammography screening settingLauro Bucchi, Alessandra Ravaioli, Flavia Baldacchini, et al.
Tumori|June 15, 2007
Risk of cancer of the prostate and of the kidney parenchyma following bladder cancerCarla Fabbri, Alberto Ravaioli, Alessandra Ravaioli, et al.
Melanoma Research|August 12, 2004
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma IntergroupRuggero Ridolfi, Antonella Romanini, Vanna Chiarion Sileni, et al.
Epidemiologia E Prevenzione|April 10, 2009
[Estimating standard performance measures of opportunistic screening for prostate cancer]Maurizio Leoni, Fabio Falcini, Alessandra Ravaioli, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
De-Implementation of Axillary Staging and Radiotherapy in Low-Risk Breast Cancer Patients Aged 70-79 Years from Six Italian Cancer InstitutesLauro Bucchi, Alessandra Ravaioli, Luigino Dal Maso, et al.
Italian Journal of Dermatology and Venereology|June 19, 2019
Melanoma survival with Classification and Regression Trees Analysis: a complement for the communication of prognosis to patientsSilvia Mancini, Emanuele Crocetti, Lauro Bucchi, et al.
Journal of Cancer Research and Clinical Oncology|March 16, 2023
Female breast cancer subtypes in the Romagna Unit of the Emilia-Romagna cancer registry, and estimated incident cases by subtypes and age in Italy in 2020Emanuele Crocetti, Alessandra Ravaioli, Orietta Giuliani, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 21, 2025
The burden of prostate cancer and metastatic prostate cancer in Italy in 2024Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, et al.
Italian Journal of Dermatology and Venereology|January 22, 2025
Estimates of the burden of skin melanoma in Italy: update to 2024Emanuele Crocetti, Federica Zamagni, Fabio Falcini, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Melanoma Research|January 8, 2019
Time trends and age-period-cohort analysis of cutaneous malignant melanoma incidence rates in the Romagna Region (northern Italy), 1986-2014Silvia Mancini, Emanuele Crocetti, Lauro Bucchi, et al.
Journal of Medical Screening|August 27, 2020
Incidence of interval breast cancer among women aged 45-49 in an organised mammography screening settingLauro Bucchi, Alessandra Ravaioli, Flavia Baldacchini, et al.
Tumori|June 15, 2007
Risk of cancer of the prostate and of the kidney parenchyma following bladder cancerCarla Fabbri, Alberto Ravaioli, Alessandra Ravaioli, et al.
Melanoma Research|August 12, 2004
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma IntergroupRuggero Ridolfi, Antonella Romanini, Vanna Chiarion Sileni, et al.
Epidemiologia E Prevenzione|April 10, 2009
[Estimating standard performance measures of opportunistic screening for prostate cancer]Maurizio Leoni, Fabio Falcini, Alessandra Ravaioli, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
De-Implementation of Axillary Staging and Radiotherapy in Low-Risk Breast Cancer Patients Aged 70-79 Years from Six Italian Cancer InstitutesLauro Bucchi, Alessandra Ravaioli, Luigino Dal Maso, et al.
Italian Journal of Dermatology and Venereology|June 19, 2019
Melanoma survival with Classification and Regression Trees Analysis: a complement for the communication of prognosis to patientsSilvia Mancini, Emanuele Crocetti, Lauro Bucchi, et al.
Journal of Cancer Research and Clinical Oncology|March 16, 2023
Female breast cancer subtypes in the Romagna Unit of the Emilia-Romagna cancer registry, and estimated incident cases by subtypes and age in Italy in 2020Emanuele Crocetti, Alessandra Ravaioli, Orietta Giuliani, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|February 21, 2025
The burden of prostate cancer and metastatic prostate cancer in Italy in 2024Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, et al.
Italian Journal of Dermatology and Venereology|January 22, 2025
Estimates of the burden of skin melanoma in Italy: update to 2024Emanuele Crocetti, Federica Zamagni, Fabio Falcini, et al.
Pageof 9